ZAc 2013.0
(-0.3%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 6.51 Billion | 3.78 Billion | 3.44 Billion | 3.23 Billion | 3.61 Billion | 3.62 Billion |
Cost of Revenue | 1.76 Billion | 1.54 Billion | 1.36 Billion | 1.31 Billion | 1.4 Billion | 1.18 Billion |
Gross Profit | 4.74 Billion | 2.24 Billion | 2.08 Billion | 1.91 Billion | 2.2 Billion | 2.44 Billion |
Operating Expenses | 2.61 Billion | 440.68 Million | 263.96 Million | 246.69 Million | 260.81 Million | 344.7 Million |
Selling, General and Administrative Expenses | 238.35 Million | 222.17 Million | 214.78 Million | 200.94 Million | 208.04 Million | 171.26 Million |
Research and Development Expenses | - | 0.59 | -0.12 | 0.83 | -2.27 | 0.42 |
Other Expenses | - | -440.68 Million | 299.05 Million | 73.03 Million | -18.71 Million | -87.21 Million |
Cost and Expenses | 2.2 Billion | 1.98 Billion | 1.62 Billion | 1.56 Billion | 1.67 Billion | 1.52 Billion |
Operating Income | 4.3 Billion | 1.8 Billion | 3.62 Billion | 2.12 Billion | -18.48 Million | 3.11 Billion |
Interest Expense | 1.86 Billion | 1.53 Billion | 975.32 Million | 851.23 Million | 1.12 Billion | 1.19 Billion |
Income Tax Expense | 1.33 Billion | -1.26 Billion | 43.07 Million | -21.99 Million | 30.38 Million | 421.5 Million |
Earnings before Tax | 3.55 Billion | 2.23 Billion | 844.86 Million | 3.37 Billion | -8.36 Billion | 3.06 Billion |
Net Income | 4.33 Billion | 5.91 Billion | 777.81 Million | 3.35 Billion | -8.36 Billion | 2.61 Billion |
Earnings Per Share Basic | 3.70 | 2.82 | 0.37 | 1.56 | -3.90 | 1.17 |
Earnings Per Share Diluted | 3.66 | 2.80 | 0.37 | 1.56 | -3.90 | 1.17 |
Weighted Average Shares Outstanding | 1.17 Billion | 2.09 Billion | 2.1 Billion | 2.14 Billion | 2.14 Billion | 2.24 Billion |
Weighted Average Shares Outstanding (Diluted) | 1.18 Billion | 2.11 Billion | 2.11 Billion | 2.15 Billion | 2.14 Billion | 2.24 Billion |
Gross Margin | 0.73 | 0.59 | 0.60 | 0.59 | 0.61 | 0.67 |
EBIT Margin | 0.35 | 0.48 | 1.05 | 0.67 | 0.01 | 0.87 |
Profit Margin | 0.67 | 1.56 | 0.23 | 1.04 | -2.31 | 0.72 |
EBITDA | 2.3 Billion | 1.8 Billion | 2.35 Billion | 2.15 Billion | -7.19 Billion | 3.15 Billion |
Earnings Before Tax Margin | 0.66 | 0.48 | 1.05 | 0.66 | -0.01 | 0.86 |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | 4.33 Billion | 2.18 Billion | 2.13 Billion | 1.6 Billion | 1.91 Billion | 3.78 Billion |
Cost of Revenue | 1.76 Billion | 873.35 Million | 891.41 Million | 470.07 Million | 759.3 Million | 1.54 Billion |
Gross Profit | 2.56 Billion | 1.31 Billion | 1.24 Billion | 1.13 Billion | 1.15 Billion | 2.24 Billion |
Operating Expenses | 332.14 Million | 35.05 Million | 1.2 Billion | 1.2 Billion | 154.2 Million | 440.68 Million |
Selling, General and Administrative Expenses | - | - | 98.45 Million | 98.45 Million | 71.83 Million | - |
Research and Development Expenses | - | 35.05 Million | 23.22 Million | - | 47.03 Million | - |
Other Expenses | -112.65 Million | 0.38 | 1.27 | - | 0.11 | -440.68 Million |
Cost and Expenses | 2.02 Billion | 1.31 Billion | 992.96 Million | 1.67 Billion | 915.13 Million | 1.98 Billion |
Operating Income | 2.3 Billion | 1.37 Billion | 2.96 Billion | 1.04 Billion | 3.12 Billion | 1.8 Billion |
Interest Expense | 1.86 Billion | - | 989.44 Million | - | 823.92 Million | 1.53 Billion |
Income Tax Expense | 1.33 Billion | 1.15 | 1.39 | 418.79 Million | 1.48 | -1.26 Billion |
Earnings before Tax | 3.55 Billion | 1.15 | 1.40 | 1.89 Billion | 1.48 | 2.23 Billion |
Net Income | 4.33 Billion | 1.19 Billion | 2.11 Billion | 1.48 Billion | 2.1 Billion | 5.91 Billion |
Earnings Per Share Basic | - | 0.72 | 0.99 | 0.70 | 0.99 | - |
Earnings Per Share Diluted | - | 0.72 | 0.99 | 0.70 | 0.99 | - |
Weighted Average Shares Outstanding | 1.17 Billion | 1.65 Billion | 2.12 Billion | 2.12 Billion | 2.11 Billion | 2.09 Billion |
Weighted Average Shares Outstanding (Diluted) | 1.18 Billion | 1.65 Billion | 2.12 Billion | 2.12 Billion | 2.11 Billion | 2.11 Billion |
Gross Margin | 0.59 | 0.60 | 0.58 | 0.71 | 0.60 | 0.59 |
EBIT Margin | - | 0.23 | 0.39 | 0.65 | -0.85 | - |
Profit Margin | 1.00 | 0.54 | 0.99 | 0.92 | 1.10 | 1.56 |
EBITDA | - | 500.28 Million | 837.59 Million | 1.04 Billion | -1.62 Billion | - |
Earnings Before Tax Margin | 0.53 | 0.63 | 1.38 | 0.65 | 1.63 | 0.48 |
FMCCT
2136
HPURF
PMTA
3563
HEMO